E
kneat.com, inc. KSIOF
$2.57 $0.072.66% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

Kneat.com, Inc. is a software company that develops and provides cloud-based validation management solutions primarily for regulated industries, with a strong focus on the life sciences, including pharmaceutical, biotechnology, and medical device companies. The company’s core offering is a software-as-a-service (SaaS) platform designed to digitize and manage validation and quality processes required to meet regulatory compliance standards such as FDA and EMA requirements.

The company generates revenue primarily through subscription fees and related professional services tied to its validation lifecycle management platform. Kneat.com is positioned as a specialized provider addressing compliance complexity in highly regulated environments, differentiating itself through deep domain expertise in validation and quality systems. Kneat.com was founded in Ireland and has evolved from a regional software provider into an internationally active company serving multinational life sciences organizations.

Business Operations

Kneat.com operates through a single primary business line centered on its proprietary SaaS platform, commonly referred to as Kneat Gx, which supports validation planning, execution, documentation, and reporting. The platform is used across equipment validation, computer system validation, and process validation, enabling customers to replace paper-based and fragmented digital systems with a centralized solution. Revenue is generated through recurring software subscriptions, implementation services, and ongoing customer support.

The company conducts operations across both domestic and international markets, with sales and service activities supporting global enterprise clients. Kneat.com controls its core software technology and intellectual property and delivers its services via cloud infrastructure. Public disclosures indicate no material reliance on joint ventures, and available public information does not identify major equity partnerships; data on certain subsidiary structures is inconclusive based on available public sources.

Strategic Position & Investments

Kneat.com’s strategic direction is focused on scaling its SaaS platform within large, regulated enterprises and expanding adoption across additional validation use cases. Growth initiatives have centered on product enhancement, customer expansion within existing accounts, and increasing penetration among global life sciences manufacturers undergoing digital transformation of quality and compliance systems.

The company has invested in platform development to support enterprise-scale deployments and integration with broader quality management ecosystems. Public filings and investor materials indicate an emphasis on organic growth rather than large-scale acquisitions; no material acquisitions have been consistently disclosed across available public sources. Kneat.com’s involvement in emerging areas such as digital validation and data integrity automation is documented, while details on specific R&D investments remain limited in public disclosures.

Geographic Footprint

Kneat.com is headquartered in Ireland, with additional operational and commercial presence in North America and Europe. The company serves customers across the United States, Ireland, the United Kingdom, and continental Europe, reflecting the global nature of its life sciences customer base.

Internationally, Kneat.com supports multinational clients with operations spanning multiple continents, and its cloud-based delivery model enables deployment across regulated facilities worldwide. While customer reach is global, disclosed physical office locations outside Ireland and North America are limited, and detailed breakdowns of regional revenue contributions are not fully specified in publicly available filings.

Leadership & Governance

Kneat.com is led by a management team with experience in enterprise software and life sciences compliance, emphasizing regulatory expertise, product reliability, and long-term customer relationships as core leadership principles. Governance is aligned with public company standards applicable to its trading status, with oversight structures disclosed in regulatory filings.

Key executives include:

  • Eddie RyanChief Executive Officer
  • Alan ClohessyChief Technology Officer
  • Orla O’ConnorChief Financial Officer
  • David MatthewsVice President of Sales

Leadership communications consistently emphasize strategic execution, disciplined growth, and maintaining high compliance standards for regulated customers.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $175.35
B
AAPL NASDAQ $252.50
B
MSFT NASDAQ $373.81
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $122.45
B
Top Financial Stocks
See All »
B
B
JPM NYSE $292.98
B
V NYSE $304.92
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $54.40
Top Health Care Stocks
See All »
B
LLY NYSE $901.32
B
JNJ NYSE $235.23
B
AMGN NASDAQ $349.92
Top Real Estate Stocks
See All »
B
PLD NYSE $130.75